Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shen Ling Jiang Tang Formula is a Traditional Chinese Medicine (TCM) herbal composition being investigated for the treatment of type 2 diabetes mellitus. Developed and studied by researchers at Dongzhimen Hospital, affiliated with the Beijing University of Chinese Medicine, the formula is designed to lower blood glucose levels and manage diabetic symptoms. It typically follows the TCM principles of tonifying Qi and nourishing Yin, which are often deficient in diabetic patients according to Chinese medical theory. The formula is currently undergoing clinical evaluation in randomized, double-blind, placebo-controlled trials to establish its efficacy and safety profile as an intervention for glycemic control in patients with inadequately controlled type 2 diabetes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shen Ling Jiang Tang Formula.